Artificial Peptides Block Infectivity of Influenza Virus

News   Sep 29, 2017 | Original story from The Scripps Research Institute (TSRI)

 
Artificial Peptides Block Infectivity of Influenza Virus

The Janssen and TSRI teams designed and characterized a potent peptide that mimicked the functionality of a broadly neutralizing antibody and which was also able to target influenza virus hemagglutinin. Image credit: Rameshwar U. Kadam (Ian Wilson's Lab)

 
 
 

RELATED ARTICLES

Targeted Drug Could be Used to Treat Advanced Cancers Located Anywhere in the Body

News

A new targeted drug could be used to treat a small number of advanced cancers no matter where they grow in the body.

READ MORE

Human Malaria Parasites Grown for the First Time in Dormant Form

News

One of the biggest obstacles to eradicating malaria is a dormant form of the parasite which is resistant to most antimalarial drugs and can reawaken years later, causing disease relapse. Researchers have shown they can grow the dormant parasite in engineered human liver tissue for several weeks, allowing them to closely study how the parasite becomes dormant, what vulnerabilities it may have, and how it springs back to life.

READ MORE

Microscopic Movie Shows How DNA Gets in Shape

News

DNA is folded into loops by a protein called condensin, and the process has been filmed for the first time.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE